Telix Pharmaceuticals TLX
NASDAQ TLX
$9.03 +0.04 (+0.44%)
At close: Oct 27, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2026)

Updated

Telix Pharmaceuticals' (TLX) Debt Ratio stood at 0.38 in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Telix Pharmaceuticals' Debt Ratio came in at 0.35, down 12.3% from the prior year.

  • Across earlier years, Debt Ratio came in at 0.40 in the year ended Dec 31, 2024 and 0.02 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,206.37 Bn 1,174.95 Bn 19.71 Bn 0.39
2 Johnson & Johnson 647.04 Bn 566.90 Bn 17.30 Bn 0.23
3 AbbVie 506.16 Bn 479.31 Bn 12.70 Bn 0.52
4 Merck 349.94 Bn 304.37 Bn 12.21 Bn 0.42
5 Novartis Ag 299.20 Bn 272.77 Bn - -
6 Astrazeneca 263.53 Bn 237.29 Bn 12.86 Bn 0.28
7 Amgen 242.16 Bn 197.56 Bn 7.24 Bn 0.60
8 Gilead Sciences 197.42 Bn 171.53 Bn 6.22 Bn 0.53
9 Pfizer 169.85 Bn 116.80 Bn 10.94 Bn 0.31
10 Telix Pharmaceuticals 3.06 Bn 2.02 Bn - 0.38
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.38
Dec 31, 2025 0.35
Dec 31, 2024 0.38
Dec 31, 2023 0.02
API Access

Telix Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TLX&period=max&api_key=YOUR_API_KEY